Quintiles’ Translational R&D Center of Excellence performs groundbreaking research and offers novel findings in oncology for biopharmaceutical companies. Quintiles provides a range of laboratory, clinical and capital solutions to help maximize the success of oncology R&D programs. Through translational research, Quintiles seeks to improve the success of drug development programs and to benefit patients by providing customers with a better understanding of therapeutic targets, molecular signaling, drug biology and patient response.